Health-Related Quality of Life and Other Patient-Reported Outcomes in the European Centralized Drug Regulatory Process: A Review of Guidance Documents and Performed Authorizations of Medicinal Products 1995 to 2003

This publication has 8 references indexed in Scilit:

• Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels
  Controlled Clinical Trials, 2004
• The European Regulatory Issues on Quality of Life Assessment Group Guidance: Some Critical Comments
  Drug Information Journal, 2003
• Incorporating the Patient's Perspective into Drug Development and Communication: An Ad Hoc Task Force Report of the Patient-Reported Outcomes (PRO) Harmonization Group Meeting at the Food and Drug Administration, February 16, 2001
  Value in Health, 2003
• The significance of quality of life in health care
  Quality of Life Research, 2003
• Patient-Reported Outcomes: The Example of Health-Related Quality of Life—a European Guidance Document for the Improved Integration of Health-Related Quality of Life Assessment in the Drug Regulatory Process
  Drug Information Journal, 2002
• Health-Related Quality of Life (HR-QOL) and Regulatory Issues
  PharmacoEconomics, 2001
• Recommendations on health-related quality of life research to support labeling and promotional claims in the United States
  Quality of Life Research, 2000
• Recommendations for Evaluating the Validity of Quality of Life Claims for Labeling and Promotion
  Value in Health, 1999